Lecture Headache
Lecture Headache
Lecture Headache
Headache
Jennifer McCombe
PGY 3
PGY-3
September 15, 2006
Overview
History:
y Past headache history y
Onset (including meds tried)
Duration Past medical history
Frequency M di ti
Medications
Course
Family history
Character
Severity Social history (including
Location alcohol and drugs,
Associated symptoms
y p
sleep, eating and
Precipitants or triggers
exercise
i h habits,
bit h how
headache affects
Prodromes
function))
Evaluation
Physical exam
KEY POINTS:
Vitals
Fundoscopy
Palpation of areas of head and neck
Auscultation of eyes, neck
Nuchal rigidity and meningeal signs
Complete neurological exam
Further evaluation of headache
Reference:
Further evaluation of headache
When to consider neuroimaging
Temporal profile and headache features:
1. The first
Th fi t or worstt headache
h d h (thunderclap
(th d l h headache)
d h )
2. Subacute headache with increasing frequency or severity
3. Progressive or new daily persistent headache
4. Chronic daily headache
5. Side-locked
6. Headache not responding to treatment
Demographics:
1. New headache in patient with cancer or HIV
2. New headache age > 50
3. Headache and seizures
CT head
Sensitivity with new scanners nears 100% within
the first 12 hours
This is provided that the images are interpreted by an
experienced neuroradiologist (or Dr. Mike Saka)
S
Sensitivity
iti it falls
f ll to
t 50% b
by 1 week
k
Therefore, in cases where clinical suspicion
i hi
is high,
h needd an LP tto rule
l outt SAH
LP needs to be analyzed for xanthochromia
Cerebral venous sinus thrombosis
CT head:
Normal exam: CT normal 25% of the time
Abnormal exam: CT normal 10% of the time
LP can have subtle abnormalities (↑RBC, ↑protein,
mild lymphocytic pleocytosis, ↑opening pressure)
Th f
Therefore, one needs
d a high
hi h iindex
d off suspicion
i i
especially in women who are pregnant or post-
partum, in patients with a history of DVT
Requires an MRI with MRV to establish or exclude
the diagnosis
Cervical artery dissection
Principles of Treatment:
Goal is to stop headache and progression of the pain
Are treatment options which are migraine specific and
th
those which
hi h are non-specific
ifi
Is best to treat early in the course of the headache to
prevent central sensitization and treatment refractory pain
Use different agents for different intensities of pain and limit
abortive therapies to 2 times per week to avoid medication
rebound headache
If requiring more frequent abortive therapies need to
recommend prophylaxis
Migraine
Treatment of the acute headache
NSAIDs
Hydration/ iv fluids
Triptans
Significant side effect is cardiac ischemia due to vasoconstriction of
the coronary arteries therefore contraindicated in those with a history
of CAD
DHE
Mostt common side
M id effect
ff t iis nausea th
therefore
f pretreat
t t with
ith an
antiemetic
Neuroleptics (metoclopromide, promethazine, prochlorperazine,
chlorpromazine)
Can cause hypotension when given iv therefore give with saline
Corticosteroids
Used in status migrainosis
Trigeminal Neuralgia
Treatment:
Spontaneous
remissions are
common
After 8 weeks of
successful therapy
therapy,
slow drug taper is
recommended
Trigeminal Neuralgia
Treatment
Approximately 30% of patients will fail medical
therapy
py and may y require
q surgical
g or ablative
procedures
Microvascular decompression is considered to be
the definitive process for idiopathic trigeminal
neuralgia
Success rate is approximately 90%
Post LP headache
Treatment:
Conservative measures:
Bedrest
Analgesia
Hydration
Caffeine
Sumatriptan
Autologous epidural blood patch
High
Hi h success rate,
t llow complication
li ti rate
t
Performing the blood patch too early increases the risk
of failure; optimal time is 24 hours post LP
Idiopathic Intracranial Hypertension
Episodes
p of visual obscurations can be monocular
or binocular and usually last less than a minute
Episodes are provoked by postural changes and the
valsalva maneuvre
No way to predict those at risk of developing
permanent visual deficits
p
Transient sixth nerve palsy is the most common
cause of episodes of diplopia
Oth less
Other, l common symptomst experienced
i d iinclude
l d
transient sensory symptoms, decreased
concentration and memory y difficulties
Idiopathic Intracranial Hypertension
Treatment
Symptomatic: focused on lowering ICP and preventing
permanent visual deficits and headache
I l d
Includes:
1. Weight loss
2. Acetazolamide (carbonic anhydrase inhibitor)
3. Furosemide
4. Topiramate
5
5. Short term oral corticosteroids
6. Surgical options: shunting and optic nerve sheet fenestration
7. Controversial: repeated lumbar punctures
Idiopathic Intracranial Hypertension
Prognosis:
g
Spontaneous recovery is common
Cessation of symptoms in 70-85% of patients within 2-3
months of medical therapy
Up to 25% have a more protracted course
Recurrence not unusual (10-40%)
V
Very slight
li ht permanentt visual
i l fifield
ld d
deficits
fi it common ((normall
formal testing in only 43% of patients) but largely
asymptomatic
9% off patients
ti t experience
i severe permanentt visual
i l field
fi ld
deficits
Up to 5% develop blindness in one or both eyes
Chronic daily headache
Reasons to image:
1. Development of progressively frequent and severe
headache within a period of 3 months
2. N
Neurologic
l i symptoms
t
3. Focal or lateralizing neurologic signs
4. Papilledema
5. Headaches aggravated or relieved by assuming an
upright or supine posture
6. H d h provoled
Headaches l db
by V
Valsalva
l l
7. Systemic symptoms or fever
8. Historyy of new headache after the age
g of fifty
y
Chronic daily headache
Treatment strategies:
Lifestyle modification:
Limiting caffeine consumption
Regular exercise
Regular mealtimes
Regular
g sleepp schedule
Preventative medications:
Tricyclic antidepressants, low dose
G b
Gabapentinti
Topiramate, low dose
Botulinum toxin type
y A
Chronic daily headache